Cooperative Agreement 2451783
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Portland, OR 97239, USA
Similar Awards
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...
- This SBIR Phase I Project Grant award of $298,646, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a rapid diagnostic test for identifying sepsis-causing pathogens from small blood volumes. The proposed DNA-based technology seeks to comprehensively detect and quantify a wide range of pathogens within a few hours, addressing limitations of current culture-based methods that require larger blood samples and...
- This Cooperative Agreement award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $1,250,000 in funding to Prompt Diagnostics, Inc. for the development of an automated point-of-care diagnostic test for infections caused by Treponema pallidum (syphilis). The project aims to create the first all-in-one diagnostic device that can rapidly and accurately detect syphilis infections in decentralized settings, enabling faster therapeutic...
- This $305,000 project grant awarded by the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of a clinical decision support system (CDSS) called Sepsis FLO. The CDSS is designed to precisely guide blood volume diagnosis and treatment for sepsis patients. Key activities include: 1) Developing an alpha prototype of the CDSS through user-centered design; 2) Validating three functional...
- This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I Project Grant, awarded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $304,966 to support the development of a portable, rapid point-of-care diagnostic device capable of simultaneously detecting and quantifying multiple blood-based biomarkers. The project aims to create an integrated cartridge/analyzer system that can automate serum separation and buffer dilution to...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $984,381 to Cobio Diagnostics Inc. in Aurora, Colorado aims to expand a diagnostic tool that enables rapid, direct-from-specimen identification and antimicrobial susceptibility testing of major bloodborne bacterial pathogens. The project will develop a regulatory pathway for FDA clearance, characterize antibodies to expand the test, and validate the expanded tests...
- This $305,000 STTR Phase I Project Grant awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an ultra-sensitive biosensor capable of protein analysis at single-molecule resolution. The biosensor consists of a nanopatterned chip with a proprietary scaffold material that binds and immobilizes molecular targets, which are then detected using surface-enhanced Raman spectroscopy (SERS). This innovation seeks...
- The National Science Foundation (NSF) has awarded a $1,000,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Aidar Health, Inc.'s Rapid Advantage Division. The purpose of this 2-year award is to develop a comprehensive remote health management system for patients with chronic kidney disease. Key deliverables include a medical device, digital tools with advanced analytics capabilities, and a novel patient engagement feature using...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 to Empo Health, Inc. supports the productization, clinical validation, and quality & regulatory activities for an in-home diabetic foot imaging bathroom scale system. The project aims to develop a novel remote health monitoring product to help reduce severe diabetic foot ulcers, which affect approximately one-quarter of diabetic patients and can lead to...